KEYSTEP-008: Phase II Trial of Pembrolizumab-Based Combination in MSI-H/dMMR Metastatic Colorectal Cancer.
Future Oncology（2023）
Key words
favezelimab,MK-4830,MSI-H/dMMR colorectal cancer,pembrolizumab,quavonlimab,vibostolimab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined